Stability of Pharmaceutical Co-Crystals at Humid Conditions Can Be Predicted

• Published in: Pharmaceutics
• Main Authors: Heiner Veith, Maximilian Zaeh, Christian Luebbert, Naír Rodríguez-Hornedo, Gabriele Sadowski
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Subjects: cocrystal; disproportionation; stability; deliquescence; moisture sorption; PC-SAFT
• Online Access: https://www.mdpi.com/1999-4923/13/3/433

Knowledge of the stability of pharmaceutical formulations against relative humidity (RH) is essential if they are to become pharmaceutical products. The increasing interest in formulating active pharmaceutical ingredients as stable co-crystals (CCs) triggers the need for fast and reliable in-silico predictions of CC stability as a function of RH. CC storage at elevated RH can lead to deliquescence, which leads to CC dissolution and possible transformation to less soluble solid-state forms. In this work, the deliquescence RHs of the CCs succinic acid/nicotinamide, carbamazepine/nicotinamide, theophylline/citric acid, and urea/glutaric acid were predicted using the Perturbed-Chain Statistical Associating Fluid Theory (PC-SAFT). These deliquescence RH values together with predicted phase diagrams of CCs in water were used to determine critical storage conditions, that could lead to CC instability, that is, CC dissolution and precipitation of its components. The importance of CC phase purity on RH conditions for CC stability is demonstrated, where trace levels of a separate phase of active pharmaceutical ingredient or of coformer can significantly decrease the deliquescence RH. The use of additional excipients such as fructose or xylitol was predicted to decrease the deliquescence RH even further. All predictions were successfully validated by stability measurements at 58%, 76%, 86%, 93%, and 98% RH and 25 °C.